Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies
Status:
Unknown status
Trial end date:
2019-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the use of sirolimus in the treatment of
children and young adults with complicated vascular anomalies will prove to be safe and
provide objective response resulting in improved clinical status and quality of life.
Funding Source - FDA OOPD (Food and Drug Administration - Office of Orphan Products
Development)